Intracranial Pressure Monitoring Devices Market Size & Share 2024 – 2032

Intracranial Pressure Monitoring Devices Market Size

Intracranial Pressure (ICP) Monitoring Devices Market size was valued at USD 1.7 billion in 2023 and is estimated to grow at a CAGR of 6.8% between 2024 and 2032. Intracranial pressure (ICP) monitoring devices are medical devices used to measure and monitor the pressure inside the skull and brain. These devices play a crucial role in the management of patients with severe traumatic brain injuries, intracranial hemorrhages, hydrocephalus, or other neurological conditions associated with elevated intracranial pressure.

The increasing prevalence of various neurological disorders and traumatic accidents has emerged as a significant public health concern worldwide. For instance, the World Stroke Organization (WSO) states that ischemic stroke poses a significant health concern, with approximately 7.6 million new cases reported each year. This persistent increase, propelled by aging and lifestyle-related factors, emphasizes the urgency for effective treatments like intracranial pressure (ICP) monitoring.
 

Furthermore,growing government initiatives and policies, rising awareness and screening programs for monitoring intracranial pressure, rising healthcare expenditure, and increasing adoption of neurostimulation devices which is set to reach USD 25.5 billion by 2032, among other contributing factors propelling the growth of the market in the forthcoming years.
 

Intracranial Pressure Monitoring Devices Market Trends

Market expansion is anticipated to be propelled by advancements in medical technologies. As, recently introduced intracranial pressure (ICP) monitoring devices are positioned to revolutionize the postoperative and critical care of patients with neurological conditions. Thus, the innovative devices provide precise measurements, allowing healthcare professionals to identify and respond promptly to changes in intracranial pressure dynamics.
 

• The transition from static to dynamic variable monitoring techniques, coupled with advancements in minimally invasive monitoring approaches, is expected to drive market expansion in the forecast period.
   
• For instance, in January 2023, Johnson & Johnson launched its new ICP monitoring system, the Codman MicroSensor ICP monitor. The monitor is a small, implantable ICP monitoring system that is designed to be less invasive than traditional ICP monitoring systems.
   
• Furthermore, technological advancements in neurotech devices enhance patient care by offering more accurate, real-time monitoring capabilities, ultimately improving outcomes for individuals with neurological conditions.
   

Intracranial Pressure Monitoring Devices Market Analysis

Based on offering, the intracranial pressure monitoring device market is bifurcated into products & systems, and solutions & platforms. The products & systems segment dominated around USD 1.1 billion revenue in 2023.
 

• Products & systems play a pivotal role in providing advanced sensors and measurement techniques, which offer precise and reliable intracranial pressure readings, thereby aiding in effective patient management.
   
• Furthermore, many products offer continuous real-time monitoring of intracranial pressure, allowing prompt detection and


• Moreover, integrated sensors provide additional parameters beyond intracranial pressure, such as cerebral perfusion pressure or brain tissue oxygenation, offering a more comprehensive assessment of neurological status, thereby fostering the segmental growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on technology, the intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment is sub segmented into external ventricular drainage (EVD), microtransducer ICP monitoring. Similarly, the non-invasive segment is sub segmented into transcranial doppler ultrasonography, tympanic membrane displacement (TMD), optic nerve sheath diameter, MRI/CT, eectroencephalography, fundoscopy (papilledema). The invasive segment is expected to cross USD 2.5 billion by the end of 2032.
 

• Invasive monitoring allows for direct measurement of intracranial pressure, providing highly accurate and reliable data for clinical decision-making.
   
• Furthermore, invasive ICP monitoring is considered the gold standard for measuring intracranial pressure. It provides continuous data, allowing healthcare providers to promptly identify and respond to changes in pressure, particularly in critically ill patients with severe traumatic brain injuries or neurological disorders.
   
• Moreover, the integration of invasive technology into ICP monitoring devices enhances accuracy, facilitates real-time monitoring, enables comprehensive assessment, and improves clinical outcomes for patients with neurological conditions.
   

Based on application, the ICP monitoring devices market is segmented into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, CSF management, migraine, stroke, hydrocephalus, and other applications. The traumatic brain injury segment accounted for 22.2% of the market share in 2023.
 

• Traumatic brain injuries can lead to elevated intracranial pressure (ICP), which, if left untreated, can result in further brain damage, herniation, and death. Monitoring ICP is crucial in these patients to detect and manage intracranial hypertension promptly. As a result, ICP monitoring devices are frequently used in the management of traumatic brain injury patients.
   
• Further, in traumatic brain injury patients ICP monitoring devices are integral components of neurocritical care protocols, allowing for continuous surveillance of intracranial pressure and timely intervention in response to changes in ICP values.
   
• Thus, the implementation of intracranial pressure (ICP) monitoring in traumatic brain injuries assessment provides critical insights and interventions that lead to better patient care, prognosis, and overall outcomes, thereby escalating the segmental growth.
   

Based on end-use, the intracranial pressure (ICP) monitoring devices market is categorized into hospitals, clinics, diagnostic laboratories, and other end-users. The hospitals segment held over USD 649.1 million revenue size in 2023.
 

• Hospitals serve as the primary centers for specialized medical care in the management of patients with neurological conditions such as traumatic brain injuries, intracranial hemorrhages, hydrocephalus, and among others. As a result, hospitals are the primary settings where ICP monitoring devices are utilized to assess and manage intracranial pressure abnormalities.
   
• Further, hospitals possess comprehensive medical infrastructure, including advanced diagnostic imaging facilities, critical care devices, neurocritical care units, and operating rooms equipped for neurosurgical interventions. As, ICP monitoring devices are integrated into this infrastructure to facilitate continuous monitoring of intracranial pressure and ensure timely intervention when necessary.
   

North America intracranial pressure monitoring market size recorded around USD 701.7 million in 2023.
 

• The region’s significant market share in intracranial pressure (ICP) monitoring devices is associated with a sophisticated healthcare infrastructure, an increasing prevalence of neurological conditions, rapid technological advancements, and significant healthcare investments.
   
• Furthermore, the growing prevalence of neurological conditions and traumatic brain injuries, coupled with advancements in medical technology, stimulate the demand for intracranial pressure (ICP) monitoring devices in the North American market.
   

Intracranial Pressure Monitoring Devices Market Share

The intracranial pressure (ICP) monitoring devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced devices based on different technologies is among a key market strategy. Some of the leading industry players including, Luciole Medical AG, Medtronic plc, Johnson & Johnson among others have a notable presence in the market.
 

Intracranial Pressure Monitoring Devices Market Companies

Some of the eminent market participants operating in the intracranial pressure (ICP) monitoring devices industry include:

• Brain4Care Inc.
• CranioSense, LLC.
• HeadSense Medical Ltd
• Integra LifeScience Holdings Corporation
• Johnson & Johnson
• Luciole Medical AG
• Medtronic plc
• Natus Medical Incorporated
• RAUMEDIC AG
• Sophysa
• Vittamed Corporation
   

Intracranial Pressure Monitoring Devices Industry News

• In March 2023, Medtronic plc announced the launch of its new intracranial pressure monitoring system, the Camino IQ. The Camino IQ is a wireless, implantable ICP monitoring system that provides continuous, real-time ICP data. Thus, this launch benefited the company by enhancing its product portfolio with an innovative and generated the sales of the company.
   
• In June 2023, Luciole Medical AG, acquired Spiegelberg GmbH & Co. KG, a Hamburg-based established provider of medical devices and consumables for neurosurgery, from SHS Capital. This acquisition allowed Luciole Medical AG to expand its portfolio of brain monitoring technologies and established a stronger presence in the neurosurgery market.
   

The intracranial pressure (ICP) monitoring devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Offering

• Products & systems
• Solutions & platforms

Market, By Technology

• Invasive
  • External ventricular drainage (EVD)
  • Microtransducer ICP monitoring 
• Non-invasive
  • Transcranial doppler ultrasonography
  • Tympanic membrane displacement (TMD)
  • Optic nerve sheath diameter
  • MRI/CT
  • Electroencephalography
  • Fundoscopy (Papilledema)

Market, By Application

• Traumatic brain injury
• Intracerebral hemorrhage
• Meningitis
• Subarachnoid hemorrhage
• CSF management
• Migraine
• Stroke
• Hydrocephalus
• Other applications

Market, By End-use

• Hospitals
• Clinics
• Diagnostic laboratories
• Other end-users

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa